• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Inhibition of key enzymes in the animal brain reduces drug relapse behavior

byJudith KandelandSarah Stapleton
October 23, 2014
in Chronic Disease, Preclinical
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. A rat drug-relapse model of cocaine, heroin or nicotine addicted animals showed elevated activity of two specific enzymes, matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) when rats, suffering withdrawal, were presented with cues they associated with drug dispensation.

2. Injecting rats with inhibitors of MMP-2 or MMP-9 prior to exposure to cocaine or its associated cues resulted in significantly less frequent self-administration of cocaine by the rats.

Evidence Rating Level: 2 (Good)

Study Rundown: Changes in neuron circuitry are characteristic of drug addiction, and enable quick relapse once an addict is reintroduced to the drug or even cues associated with it. Matrix metalloproteinases (MMPs) are enzymes that participate in neuron remodeling by degrading the matrix surrounding cells, and have been broadly shown to be involved in neuronal alterations distinctive of drug addicts. This study sought to identify specific MMPs involved in drug addiction, and particularly in addicts’ susceptibility to relapse. The authors used an experimental model in which rats were allowed to self-administer cocaine, heroin or nicotine by pressing a lever, then withdrawn from the drugs, and later exposed to either drug itself or the sensory cues (a light and noise) they associated with drug dispensation.

Elevated activity of MMP-2 and MMP-9 (called gelatinases) were found in cocaine- or nicotine-withdrawn rats, an effect which was lessened by administration of a pharmacological inhibitor of MMP-2. Gelatinases were further stimulated 15 minutes following exposure to drug-associated cues, and 45 minutes following reintroduction of cocaine itself. In these two experiments, a MMP-9 inhibitor decreased the gelatinase activity. Microinjecting either inhibitor prior to presenting cocaine-associated cues or actual cocaine injection decreased the number of following lever presses. These experiments yielded evidence for the separate and important roles MMP-9 and MMP-2 play in both withdrawal- and relapse-associated brain remodeling, and that inhibitors of these molecules suppress the relapse behavior of rats. Whether the important roles found for gelatinases hold true for human addiction remains to be studied. If so, these findings may point to the use of gelantinase inhibitors as possible treatment methods for drug addiction.

Click to read the study in Nature Neuroscience

Relevant Reading: The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens

RELATED REPORTS

Nicotine e-cigarettes may help young adults stop smoking

Transgender veterans may be more likely to use amphetamine, cocaine, and cannabis than cisgender veterans

Wellness Check: Addictions

In-Depth [animal study]: This study included over 100 rats, with several rats in each of the many groups studied. Rats were ~65 days old when they received intrajugular catheters for drug infusion, with some rats additionally given an intracranial cannulus. Recovery from surgery lasted 5 days, and the next 10 days involved daily 2-3 hour sessions of self-administration of cocaine, heroin, or nicotine potentiated by lever pressing. Drug infusion was accompanied by a light and a noise. The next stage involved extinction, in which lever pressing ceased to result in drug infusion and its accompanying cues, and led to fewer lever pressings. Rats then underwent reinstatement, in which they were exposed to either the light/noise combination or to cocaine itself, which both resulted in much more frequent lever pressing. Gelatinase activity was assessed by intracranial injection of dye-quenched FITC-gelatin, which fluoresces when degraded by gelatinases. Rats were sacrificed 15 minutes later and their brains were analyzed for fluorescence density.

Cocaine and nicotine extinction increased gelatinase activity compared with controls (p<0.05), and use of an MMP-2 inhibitor reduced this effect in cocaine-addicted rats (p<0.05). Gelatinase activity was further increased for all drugs 15 minutes following cue-induced reinstatement (p<0.001) or 45 minutes following cocaine-mediated reinstatement (p<0.001). These increases were reduced by prior injection of a MMP-9 inhibitor (p<0.05). Intracranial injection of either inhibitor reduced lever pressing upon cue-induced reinstatement in a dose-dependent manner (p<0.001), and the MMP-9 inhibitor also reduced lever pressing following cocaine-induced reinstatement (p<0.001).

Image: PD/DEA

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: cocainedrugsheroinnicotine
Previous Post

Second-hand fine particulates dangerously elevated in smoking homes

Next Post

Laparoscopic colon cancer management may be beneficial in elderly

RelatedReports

Smokeless tobacco use in children has not changed
Wellness

Nicotine e-cigarettes may help young adults stop smoking

October 25, 2021
Participation in sports and exercise linked to lower opioid use
Wellness

Transgender veterans may be more likely to use amphetamine, cocaine, and cannabis than cisgender veterans

October 22, 2021
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Wellness

Wellness Check: Addictions

October 21, 2021
PD
Wellness

Heterogenous pattern of cocaine usage in the United States

September 24, 2021
Next Post
Laparoscopic colon cancer management may be beneficial in elderly

Laparoscopic colon cancer management may be beneficial in elderly

Group B streptococcus infections on the rise despite prevention guidelines

Group B streptococcus infections on the rise despite prevention guidelines

Shortened tuberculosis treatment regimen inferior to standard

Shortened tuberculosis treatment regimen inferior to standard

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transcarotid artery revascularization not associated with a significant difference in 30-day risk of stroke, death and myocardial infarction compared to carotid endarterectomy
  • Drinking characteristics in adolescence predict alcohol behaviors in early adulthood
  • Sodium-glucose co-transporter-2 inhibitors may decrease risk of in-stent thrombosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options